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ABSTRACT
Objective: A comparison between office hysteroscopy,
transvaginal ultrasonography and endometrial biopsy was
performed, in terms of detection of intrauterine lesions. A
secondary objective was assessment of evaluatory
approach in the management of abnormal uterine bleeding
in an outpatient setting.
Design: Prospective observational study.
Material and Methods: A total of 54 women were eval-
uated for abnormal uterine bleeding. Assessment included
performance of an endometrial biopsy, a transvaginal ultra-
sound scan followed by office hysteroscopy. Results of
hysteroscopy were taken as the gold standard. Sensitivity
and specificity of the investigations were assessed. The
bleeding pattern was classified as heavy regular, irregular,
postmenopausal and heavy or unscheduled bleeding on
hormone replacement therapy.
Results: The incidence of focal intrauterine lesions in
patients presenting with abnormal bleeding was 52% for all
ages and 31% for the postmenopausal group. Seventy-five
percent of the patients with Hb < 11 gm% and 67% with an
enlarged uterus harbored a focal pathology. The incidence
of lesions in patients with heavy regular bleeding was 74%.
The sensitivity and specificity of transvaginal ultrasound
when compared with results of hysteroscopy was 0.60 and
0.88 respectively. A normal endometrial biopsy had a neg-
ative predictive value of 51%. The sensitivity and specifici-
ty of endometrial biopsy were 0.04 and 0.83, respectively.
Conclusion: Both transvaginal ultrasound and endome-
trial biopsy exhibited poor sensitivity for detection of focal
intrauterine lesions. Considering the significantly high inci-
dence of intrauterine lesions in patients presenting with
abnormal bleeding, the most cost-effective approach
appears to be proceeding with hysteroscopy early in
assessment.
Key Words: Abnormal uterine bleeding, Office hys-
teroscopy, Endometrial biopsy, Transvaginal ultrasound
scan.
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INTRODUCTION
Abnormal uterine bleeding (AUB) accounts for a significant
proportion of gynecological referrals. Evaluation of the
problem has included investigations ranging from the tra-
ditional diagnostic dilatation and curettage (D&C), office
based endometrial biopsy (EMBx), to pelvic ultrasonogra-
phy for evaluation of endometrial/myometrial pathology
contributing to the presentation. Diagnostic hysteroscopy
for direct assessment of the uterine cavity has been a rela-
tively recent acquisition in the armamentarium of the gyne-
cologists. In an outpatient setting, the entire evaluatory
workup takes at least two to three visits prior to arriving at
a definitive diagnosis and commencement of appropriate
therapy.
In the current scenario of increasing cost awareness and an
ever-increasing litigious environment, a balance has to be
achieved between the practice of "blanket" medicine aim-
ing at performance of all investigations possibly contribut-
ing to a diagnosis versus a condition appropriate approach.
The study presented was undertaken to evaluate the sensi-
tivity and specificity of EMBx and transvaginal ultrasound
TVS for detection of intracavitary uterine lesions compared
with results of office hysteroscopy (OH), which were taken
as the gold standard. A secondary objective of the study
was to evaluate the protocol for assessment of the common
problem of AUB. Appropriate management could thus be
instituted at the earliest possible opportunity, minimizing
the number of unnecessary investigations as well as the
numerical patient visits to the clinic, without compromising
the quality of patient care.
DESIGN
Prospective observational study conducted at the
Department of Gynecology at Massachusetts General
Hospital (MGH) between January, 1995, and September,
1996.
MATERIALS AND METHODS
Patients attending the gynecology department at MGH with
complaints of abnormal uterine bleeding were evaluated
for inclusion in the study. The catchment population was
from the resident managed gynecology clinic and from
practices of two attending physicians with a special interest
in reproductive endocrinology. AUB was defined as either
cyclic excessive bleeding, irregular menstrual cycles, post-
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menopausal bleeding, and excessive or unscheduled with-
drawal bleeding on hormone replacement therapy (HRT).
Each patient presenting underwent a preliminary assess-
ment by history and clinical examination; pap smear status
was evaluated and updated if indicated. The bleeding pat-
tern was categorized as regular or irregular. The uterine
size was assessed clinically and determined as normal or
enlarged.
The study protocol aimed at obtaining an outpatient
endometrial biopsy (EMBx) usually at the initial presenta-
tion, followed by a transvaginal pelvic ultrasound (TVS).
An office hysteroscopy (OH) was then scheduled at a sub-
sequent visit. Other than OH, the other investigations were
performed without consideration of the phase of the
menstrual cycle; OH was scheduled in the early prolifera-
tive phase of the menstrual cycle in patients complaining of
regular AUB.
The EMBx was performed using a Pipelle biopsy sampler
(Unimar, Inc. Connecticut). Aseptic precautions were
employed by cleansing the cervix with betadine prior to
insertion of the catheter. Antibiotic prophylaxis was given
if indicated, using Doxycycline 100 mg bid for 5 days.
The TVS was performed in an office setting by one of the
two attendings in gynecology. The uterine anatomy and
the adnexae were visualized using a 7.5 MHz vaginal probe
transducer (General Electric, Milwaukee, RT 3200
Advantage II real time sector scanner). Appearance of the
endometrial stripe was commented upon as either normal
or abnormal; a specific note was made of any focal lesion
seen in terms of impression of an endometrial polyp, sub-
mucous fibroid, intramural fibroid, suspicion of hyperplasia
or endometrial carcinoma. The contour of the endometri-
al stripe was assessed in the midline sagittal plane and the
point of maximum thickness of the stripe (ET) was mea-
sured on a frozen image at 1.5x magnification.
Office hysteroscopy (OH) was performed using a 3.6 mm
single channel flexible hysteroscope (HYF-P Olympus
America, NY) with a fiberoptic cold light source; normal
saline was used as the distending medium and the proce-
dure was performed under direct video monitoring.
A total of 54 patients completed the study and underwent
EMBx, TVS and OH. In none of the OH procedures was
cervical dilatation required, nor was any form of local anes-
thetic used.
Baseline laboratory investigations included a complete
blood count, results for which were available for 47
patients.
The results of OH were taken as the "gold standard" for
detection of intracavitary pathology as a contributing factor
to the clinical presentation. Sensitivity and specificity of the
EMBx and TVS in detecting the intracavitary lesions were
calculated. The sensitivity of clinical finding of an enlarged
uterus and the pattern of bleeding in predicting an intra-
cavitary lesion were also estimated, as was the association
of significant anemia (Hb < 11 gm%) and the incidence
of concomitant intrauterine lesions. An age-related preva-
lence of intracavitary lesions (submucous fibroids / polyps
/ endometrial hyperplasia / chronic endometritis / endome-
trial cancer) was calculated in the study population.
Statistical analysis was performed using unpaired t tests
using the statistical package GraphPAD in Stat version 1.01.
A 'P' value of < 0.05 was considered as statistically signifi-
cant.
RESULTS
The age range for the patients was 19-74 years. Thirteen
patients were postmenopausal. Fifty-two percent of the
patients presenting with abnormal uterine bleeding had
evidence of an intracavitary lesion as detected by office
hysteroscopy. Congenital uterine anomalies detected inci-
dentally on OH included one case each of a unicornuate,
and bicornuate and two cases of septate uterus.
(TVS) performed detected a distortion of the endometrial
cavity suggestive of a focal pathology in 20 patients. A sub-
sequent OH confirmed the diagnosis in 17/20 cases where
a focal lesion was suspected (Table 1). However, of the 34
patients in whom TVS showed a normal endometrium, OH
confirmed 11 false negative cases. The sensitivity of an
abnormal transvaginal ultrasound scan when compared to
office hysteroscopy for detection of an intracavitary lesion
was thus calculated as 0.60. The specificity for a normal
TVS was determined as 0.88. Of the 11 false negative TVS
results, OH demonstrated five cases of endometrial polyp
and six submucous myomas; in 5/6 of the latter there was
Table 1.
Detection of intracavitary uterine lesions: Comparison of results
of office hysteroscopy to transvaginal ultrasound.
TVS
Abnormal
Normal
Total
Office hysteroscopy
Abnormal
17
11
28
Normal
3
23
26
Total
20
34
54
TVS: Transvaginal ultrasound
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Of the 54 patients who underwent TVS, a specific mention
of the thickness of the endometrial stripe was available in
28, the thickness of the endometrium (ET) ranging from
1.8 mm to 25 mm. When correlating the thickness in mm
with the presence of intracavitary lesions confirmed by OH,
it was noted that the ET 6 mm had a negative predictive
value of 92%; ET of 10 mm had a positive predictive
value of 89%.
The highest prevalence of intracavitary lesions was seen in
the age group of 36-40 years (71%); in the < 30 years age
group, the incidence was 50%, the difference in the preva-
lence between the different ages not being of statistical sig-
nificance (Table 2). Submucous myomas were the most
common lesions seen in the younger patients; an increas-
ing incidence of endometrial polyps was seen with increas-
ing age, polyps being the most frequently diagnosed
pathology in the postmenopausal women, as shown in ear-
lier studies.
1
Table 2.
Age related prevalence of intracavitary lesions
determined by OH.
Age (years)
a35
36-40
41-50
>51
Number of
patients
6
14
20
14
Abnormal
OH
3
10
11
5
Percentage
50%
71%
55%
36%
The endometrial biopsy (EMBx) specimens were consid-
ered adequate for reporting in 49/54 cases; two samples
had inadequate tissue and three specimens showed men-
strual blood, making interpretation difficult. No evidence
of pathology was seen in 44/49 specimens. Of the patients
with a normal EMBx, 19 were true negative and 25 were
false negative, when compared to results of OH (Table 3).
The negative predictive value of a normal EMBx was cal-
culated as 51%. In 5/49 biopsy specimens, a pathology was
detected and included fragments of endometrial polyp in
two cases; office hysteroscopy confirmed the presence of a
residual polyp in one of these patients. There was evidence
of chronic endometritis in one patient, in whom an
endometrial polyp was detected on hysteroscopy, and focal
hyperplasia within a secretory endometrium was shown in
the fourth patient, who had a normal appearing endome-
trial cavity on OH. The sensitivity of endometrial biopsy
was 0.04 with a specificity of 0.83. No pathological evi-
dence of endometrial carcinoma was detected in the EMBx
specimens available, which included 14 specimens from
postmenopausal patients. The incidence of inconclusive
sampling was 9% and that of focal endometrial hyperplasia
was 2%.
Table 3.
Detection of intracavitary uterine lesions: Comparison of results
of office hysteroscopy to endometrial biopsy.
Endometrial biopsy
Normal
Abnormal
Total
Office hysteroscopy
Abnormal
1
25
Normal
4
19
Total
5
44
49*
* Interpretation for 5/54 EMBx specimen was inconclusive. See Text.
Of the 13 postmenopausal patients, the age range was 47-
74 years; seven patients were on some form of HRT for a
period of at least three months prior to the presentation.
The prevalence of intracavitary lesions in the post-
menopausal group was 31% (4/13); two of the lesions were
confirmed to be benign endometrial polyps on histology
and the third was a submucous myoma; in the fourth
patient the biopsy of an irregular focal area of the
endometrium provided a benign proliferative histological
specimen. Results of TVS specifically noted endometrial
thickness in 10 postmenopausal patients, the thickness
ranging from 1.8 mm -15 mm. In 7/10 patients, the ET was
< 6 mm and 6/7 had a normal uterine cavity of OH; the sev-
enth patient, a 72-year-old woman, was noted to have an
area of endometrial irregularity on the anterior uterine wall
and a directed biopsy performed showed histological evi-
dence of proliferative endometrium with no evidence of
malignancy. Of the three postmenopausal patients in
whom a TVS showed an endometrial thickness of greater
than 6 mm, all were found to have an endometrial polyp
on OH. Thus taking the ET of 6 mm as the cut-off in the
postmenopausal women, the positive predictive value for
detection of intracavitary lesions for ET > 6 mm was deter-
mined to be 100%, whereas the negative predictive value
for an ET of < 6 mm was also calculated as 100%.
Of the 54 patients included in the evaluation, 26 underwent
definitive surgical management for the presenting problem;
two patients had a normal uterine cavity and opted to
undergo endometrial ablation, whereas 24 had operative
hysteroscopic resection of the focal lesion.
Histopathological tissue diagnosis was available for 23/24
of these cases. The most common histological diagnosis
was a submucous myoma, seen in 65%, followed by
benign endometrial polyps in 26% of the resected lesions;
in 5%, a combination of the two existed. There was no evi-
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Table 4.
Pattern of abnormal uterine bleeding and associated
uterine intracavitary abnormalities.
dence of focal atypia in any of the histology specimens.
The uterus was classified as normal in size on clinical
examination in 63% of the patients (36/54). Of the 18
enlarged uteri, 12 showed an intracavitary lesion on OH,
giving a PPV of 67%. In eight of the 47 patients in whom
a CBC was available, the hemoglobin was less than 11
gm%; 6/8 (75%) of these patients had an abnormal finding
on OH. Nineteen of the 54 patients were experiencing
heavy, though regular menstrual flow; of these, 14 (74%)
had an abnormal OH compared to 14/35 (40%) of those
presenting with irregular bleeding, the difference in the
prevalence of lesions being statistically significant
(P=0.008).
Bleeding pattern Number of patients Intracavitary
Regular heavy
Irregular and /or
heavy
Total
19
35
54
lesion of OH
14a*
14b*
28
Difference between a and b is statistically significant P<0.05
DISCUSSION
The high incidence of intrauterine lesions (52%) in our
patient population presenting with abnormal uterine bleed-
ing (AUB) is consistent with results of earlier studies.
1 The
traditional approach to evaluation of AUB in an outpatient
setting has included an endometrial sampling following a
preliminary assessment based on the history and clinical
examination. The patient commonly makes an average of
two to three clinic visits, depending on the urgency of pre-
sentation, before being commenced on a specific treatment
protocol.
In the present era of cost containment and capping of pro-
cedure related reimbursements, the physicians should be
acquainted not only with the relative informative yield but
also the cost per investigation, so as to channelize their
diagnostic approach. The aim of management is to thus
minimize the cost incurred per patient, while adhering to
the principals of the standard of care.
Diagnostic hysteroscopy, though being increasingly
employed for evaluation of AUB, is still underutilized.
Since the introduction of the hysteroscopic technique, the
procedure has undergone significant modifications, con-
tributing to an increase in patient acceptance. Introduction
of fiberoptics, reduction in the caliber of the endoscopes,
use of simpler distending media and availability of safer
local infiltrative anesthetics have all contributed to an
increasing utilization of this technique in evaluation of the
uterine cavity. Baskett et al.
2 in a recent commentary on
the efficiency of a one-stop menstrual clinic have demon-
strated the cost and clinical effectiveness of utilizing hys-
teroscopy as a preliminary investigation performed at the
initial visit in selected patients. The results of our study
agree with their rationale. More than 50% of all diagnostic
hysteroscopies, however, are still being performed in the
operating room (OR), and this trend could be attributed to
a combination of a lack of awareness on the part of the
physician and perhaps nonavailability of smaller caliber
endoscopes. Compared to TVS, hysteroscopy allows for a
direct visualization of the endometrial cavity and hence
detection of any focal lesion. It offers the additional oppor-
tunity of obtaining a directed biopsy in the same setting if
indicated, thus obviating the need for a separate schedul-
ing of the procedure. Studies have demonstrated a superi-
or yield of directed biopsies compared to D&C in provid-
ing representative histological specimens.
3,
4 In terms of
cost containment, the procedure being performed by the
investigating gynecologist precludes the involvement, and
hence need for reimbursement of an additional specialist.
Furthermore, it dictates the need for a histological speci-
men if indicated, and allows for a directed biopsy, ensuring
provision of a representative specimen of the focal pathol-
ogy for evaluation. Performing an OH early in the evalua-
tion in appropriately selected patients would render utiliza-
tion of any further investigation like EMBx or TVS unnec-
essary. The net result would ensure cost containment by
reduction in the number of patient visits for investigational
purposes, and by enabling the physician to embark on an
appropriate management plan at the earliest opportunity,
contribute significantly to patient satisfaction.
The significant incidence of intrauterine lesions in the post-
menopausal patients evaluated (31%) is comparable to
other studies
5,
6 and underscores the importance of direct
visualization of the uterine cavity in this subgroup. Since
this represents the patient population at the highest risk for
significant uterine pathology, i.e. endometrial carcinoma,
and because the hysteroscopic appearances of early lesions
are well recognized,
7 the argument is further strengthened
in favor for an early visualization of the cavity. An insight
into the clinical staging of an existing endometrial carcino-
ma would be an additional benefit contributing to the final
management plan.
The high incidence of intracavitary lesions seen in the
patients with clinically enlarged uteri (62%) and in those
with significant anemia (80%) underscores the importance
of proceeding with OH early in the evaluatory process in
this subcategory of patients.
The rationale for attempting to evaluate the endometrial
128 JSLS (1997)1:125-130specimen histologically, obtained by either D&C or outpa-
tient biopsy, is to provide an early diagnosis of a significant
pathology, namely endometrial cancer and/or endometrial
hyperplasia. While the risk of such an occurrence is high
in a subset of patients, i.e. postmenopausal women with
abnormal bleeding (10%), anovulatory patients and those
with a history of prior endometrial hyperplasia, the yield of
endometrial sampling from the rest of the patient popula-
tion in terms of obtaining a pathological diagnosis is negli-
gible. This is consistent with our data and questions the
almost universal practice of biopsying the endometrium in
any patient presenting with AUB. In our experience, an
expenditure of approximately $250 for an EMBx could be
easily avoided in the majority of premenopausal patients
with AUB. An EMBx, however, has a definite place in the
diagnostic workup of postmenopausal patients as well as
those premenopausal patients who are at high risk for
endometrial hyperplasia. The high propensity of missing
focal intrauterine lesions like submucous myomas and
polyps with D&C is well documented in recent litera-
ture. 3,4,8,9 Moreover, the alleged therapeutic effect of D&C
in the management of AUB remains questionable.
3
,
 4,1
0
Most of the data available on the diagnostic accuracy of
TVS in evaluation of abnormal uterine bleeding is relevant
only for the postmenopausal patients.
11,1
2 The general con-
sensus of opinion is that an endometrial thickness of less
than 5-6 mm in a patient presenting with postmenopausal
bleeding does not warrant an extensive workup, as the risk
of endometrial carcinoma and/or hyperplasia is negligi-
ble.
11,1
3 The sensitivity and specificity of TVS in detecting
focal intrauterine lesions in the study presented is compa-
rable to the results shown by Tombin et al. ( 0.54 and 0.40,
respectively). Scheduling the ultrasound evaluation in the
follicular phase of the menstrual cycle in the pre-
menopausal patients may enhance the sensitivity since the
hyperechoic secretory endometrium may mask the
endometrial polyps.
14,1
5 Presence of intramural myomas
may obscure the endometrial stripe, thus contributing to a
significant incidence of false negative interpretations, as
shown in our series. The majority of pelvic ultrasound
scans are still being performed by the radiologists; the cost
of a TVS ranges from $250-$400, depending on the involve-
ment of the radiology department. Furthermore, an impres-
sion of an intracavitary lesion directs the management
towards performance of a hysteroscopic procedure for the
ultimate diagnosis and management.
CONCLUSION
There is a high incidence of intracavitary uterine pathology
in patients presenting with abnormal uterine bleeding. This
is especially true when considering the 35-50 years age
group who present with heavy regular bleeding, clinically
enlarged uteri and significant anemia. The relatively poor
sensitivity of both endometrial biopsy and transvaginal
ultrasound in the detection of intrauterine focal pathology
encourage us to propose that OH be utilized as a first line
investigation in these patient evaluations. The cost-benefit
analysis of investigations like EMBx and TVS as well as the
financial burden of clinic visits during the entire evaluatory
process further strengthens the validity of the proposed
approach.
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